1. Home
  2. XTNT vs SQNS Comparison

XTNT vs SQNS Comparison

Compare XTNT & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XTNT
  • SQNS
  • Stock Information
  • Founded
  • XTNT N/A
  • SQNS 2003
  • Country
  • XTNT United States
  • SQNS France
  • Employees
  • XTNT N/A
  • SQNS N/A
  • Industry
  • XTNT Biotechnology: Biological Products (No Diagnostic Substances)
  • SQNS Semiconductors
  • Sector
  • XTNT Health Care
  • SQNS Technology
  • Exchange
  • XTNT Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • XTNT 69.3M
  • SQNS 70.9M
  • IPO Year
  • XTNT N/A
  • SQNS 2011
  • Fundamental
  • Price
  • XTNT $0.59
  • SQNS $3.18
  • Analyst Decision
  • XTNT Strong Buy
  • SQNS Strong Buy
  • Analyst Count
  • XTNT 1
  • SQNS 1
  • Target Price
  • XTNT $3.00
  • SQNS $7.50
  • AVG Volume (30 Days)
  • XTNT 83.6K
  • SQNS 160.0K
  • Earning Date
  • XTNT 11-12-2024
  • SQNS 03-06-2025
  • Dividend Yield
  • XTNT N/A
  • SQNS N/A
  • EPS Growth
  • XTNT N/A
  • SQNS N/A
  • EPS
  • XTNT N/A
  • SQNS 1.65
  • Revenue
  • XTNT $113,862,000.00
  • SQNS $30,555,000.00
  • Revenue This Year
  • XTNT $31.27
  • SQNS $10.14
  • Revenue Next Year
  • XTNT $13.07
  • SQNS $8.54
  • P/E Ratio
  • XTNT N/A
  • SQNS $1.82
  • Revenue Growth
  • XTNT 45.11
  • SQNS N/A
  • 52 Week Low
  • XTNT $0.33
  • SQNS $0.85
  • 52 Week High
  • XTNT $1.30
  • SQNS $7.43
  • Technical
  • Relative Strength Index (RSI)
  • XTNT 73.52
  • SQNS 51.85
  • Support Level
  • XTNT $0.49
  • SQNS $2.81
  • Resistance Level
  • XTNT $0.55
  • SQNS $3.21
  • Average True Range (ATR)
  • XTNT 0.07
  • SQNS 0.25
  • MACD
  • XTNT 0.01
  • SQNS -0.05
  • Stochastic Oscillator
  • XTNT 95.48
  • SQNS 45.68

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: